NBTX Nanobiotix

P/E --
Forward P/E 42.37
Price/Sales 114.31
Beta 0.591
Div Yield --
Market Cap --

Company Analysis

Latest News

🔴 Nanobiotix is trading 5% down today amid a broader biotech-sector selloff

Nanobiotix is trading $33.44, down 5.12%, as a broader biotechnology selloff pressures the stock rather than a newly reported company-specific setback. - The...

🟢 Nanobiotix is trading 5% up today as broader markets rally

Nanobiotix is trading 5.08% up at $34.73 as broader markets rally. - On September 21, 2026, the Nasdaq Composite is up 2.13% and the S&P 500 is up 1.49%. - No...

🔴 Nanobiotix is trading 5.2% down today despite broader biotech strength

Nanobiotix is trading 5.2% down at $34.00 based on the provided live price, with no clear company-specific negative catalyst emerging for September 18,...

🔴 Nanobiotix is trading 5.9% down in pre-market as Nasdaq futures fall 1.78%

Nanobiotix is trading 5.88% down now at $34.83 after opening September 14, 2026, amid a weaker market backdrop. - Nasdaq futures were down 1.78%, with...

🟢 Nanobiotix is trading 5% up today with no clear company-specific catalyst

Nanobiotix is trading at $38.55 (+5.21%) with no clear company-specific catalyst identified for September 10, 2026. - Nanobiotix announced participation in an...

🔴 Nanobiotix is trading 6.8% down today with no clear company-specific catalyst identified

Nanobiotix is trading 6.78% down at $35.60, with no clear company-specific announcement identified for September 9, 2026. • Broader risk-off sentiment and...

🔴 Nanobiotix is trading 7.4% down in pre-market with no clear company-specific announcement identified

Nanobiotix is trading 7.4% down now at $35.36 after no clear company-specific announcement was identified for September 9, 2026. - Broader sentiment is...

🔴 Nanobiotix is trading 5.1% down today despite broader market and biotech gains

Nanobiotix is trading 5.1% down at $39.54, with no fresh company-specific announcement or clearly disclosed catalyst for September 3, 2026 identified. -...

🟢 Nanobiotix is trading 10.23% up today as broader biotech-sector strength

Nanobiotix is trading $43.31, 10.23% up now, supported by broader biotech-sector strength. - The stock rebounded from its September 1, 2026 close of $39.29. -...

🟢 Nanobiotix is trading 6.77% up today with no clear company-specific catalyst identified

Nanobiotix is trading 6.77% up at $41.95, rebounding after closing at $39.29 on September 1, 2026; no clear company-specific catalyst has been identified for...

🔴 Nanobiotix is trading 5.3% down today after profit-taking amid biotech weakness

Nanobiotix is trading 5.3% down now at $42.75 after profit-taking following its recent gains. - No fresh company-specific announcement, earnings release, or...

🔴 Nanobiotix is trading 5.1% down in pre-market amid cited profit-taking

Nanobiotix is trading 5.1% down at $42.25 in a decline that appears technically driven, with profit-taking and negative momentum cited. - It closed at $44.50...

🟢 Nanobiotix is trading 6% up today as XBI ETF rises 2.06%

Nanobiotix is trading at $43.99, up 5.97%, primarily linked to biotech-sector strength, with the XBI ETF up 2.06%. - The move extends Nanobiotix’s rebound...

🟢 Nanobiotix is trading 5.47% up today as biotech ETF XBI gains 2.06%

Nanobiotix is trading at $41.83, up +5.47%, appearing primarily driven by biotech-sector strength. - No new company-specific announcement or analyst action...

🔴 Nanobiotix is trading 8.3% down today amid broader risk-off market pressure

Nanobiotix is trading 8.3% down at $39.95 amid broader risk-off pressure, with no fresh company-specific announcement or analyst action identified for August...

🔴 Nanobiotix is trading 5% down today as biotech stocks retreat after Moderna’s cancer-vaccine rally

Nanobiotix is trading lower at $43.06, down -5.13%, on August 20, 2026, as biotechnology shares give back gains following Moderna’s historic cancer-vaccine...

🟢 Nanobiotix is trading 5.9% up today on Moderna’s positive personalized cancer-vaccine Phase 3 results

Nanobiotix is trading 5.9% up now at $43.10 after biotech-sector strength lifted sentiment. - Biotech is rising 3.73%, supported by Moderna’s positive...

🟢 Nanobiotix is trading 7.5% up in after-hours trading with catalyst still unconfirmed

Nanobiotix is trading at $45.21, up 7.51%, with no confirmed catalyst identified. - Nanobiotix gained 9.76% during the August 17 regular session before...

🟢 Nanobiotix is trading 10.3% up today; catalyst remains unclear

Nanobiotix is trading 10.3% up at $42.26, but the catalyst remains unclear. - No clearly dated August 17, 2026 company-specific announcement, earnings...

🟢 Nanobiotix is trading 5% up

Nanobiotix is trading 5.1% up at $40.25, based on the provided live price context; no clear company-specific catalyst has been identified. - Searches found no...